$SNPS

Glaser Shelagh sold $1.5M of SNPS (indirect holdings)

Glaser Shelagh (CFO) sold 3,394 indirectly-held shares of SYNOPSYS INC (SNPS) at $450.02 ($1.53M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Glaser Shelagh
Published Jun 15, 2026, 6:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

A senior officer’s open-market sale is disclosed with transaction size, price, and post-transaction holdings; no new operating or market-moving information is provided.

02

Market read

Primarily a sentiment/positioning datapoint; likely limited incremental impact versus broader company fundamentals.

03

What to watch

Traders may over-weight insider sales; without changes in guidance, contracts, or regulatory developments, the signal is usually weak.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-15; transaction dated 2026-06-12.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Synopsys.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Synopsys CFO Glaser Shelagh filed an SEC Form 4 selling 3,394 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and no accompanying fundamental catalyst (no guidance, deal, or regulatory action).

Market effects

Minimal; insider selling at a single software name rarely changes sector fundamentals.

Minimal; no cross-asset or macro linkage stated.

Minimal; transaction is company-specific and not tied to global events.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.

Key entities

  • Synopsys

    Company whose CFO filed the Form 4 insider sale disclosure.

  • Glaser Shelagh

    CFO reporting an open-market sale of SNPS shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNPSMedAI 8/10

Should $1b Amazon Deal Require Action From Synopsys (SNPS) Investors?

Synopsys (SNPS) announced a multiyear, $1B+ deal with Amazon to expand the use of its EDA, IP, and AI-based engineering tools for custom silicon. The agreement aligns with Synopsys' AI-centric roadmap and long-term financial goals. Analysts highlight potential demand visibility and capital allocation influences, while noting risks like Ansys integration and litigation. Current earnings are $1.1B, with forecasts for $2.6B by 2029, implying 13% yearly revenue growth.

$SNPSHigh

Synopsys (SNPS) Announces $1 Billion Accelerated Share Repurchas

Synopsys (SNPS) announced a $1 billion accelerated share repurchase agreement with JPMorgan Chase, aiming to buy back 1.7 million shares initially. The company's shares rose over 1% in pre-market trading. According to GuruFocus, SNPS is modestly undervalued by 24%, with a GF Value of $659.43. The company has a GF Score of 95/100, indicating strong financial health and growth potential. However, insider activity shows no purchases and $48.2 million in sales over the past year.